Executive Change

New York – October 13, 2026 -- New York Public Radio (NYPR) said President and CEO Christy Tanner will step down, and a three-person interim Office of the CEO will run the organization while its Board of Trustees searches for a permanent successor.

Three board-linked media executives form a temporary Office of the CEO

The interim team consists of current Board members Jenna Weiss-Berman and Gary Knell, plus LaFontaine Oliver. Oliver will also serve as interim acting President.

All three have established ties to NYPR and to the wider media sector:

Washington – October 12, 2026 -- Jennifer Hedrick, CAE, has stepped down as President & CEO of the Women In Trucking Association (WIT), effective Aug. 5, after serving in the role since January 2023.

Vice President Lana Nichols takes over as interim president and CEO

WIT's Board of Directors will direct the search for a permanent successor. Lana Nichols, the association's Vice President, will run the organization in the interim. WIT said additional information on the leadership transition will be shared as it becomes available. No timeline for the search was disclosed.

Stockholm – October 12, 2026 -- Nadine Crauwels, President of Sandvik's Machining business area since 2020, is leaving the group after 26 years, with the company aiming to name a successor before the end of 2026.

Crauwels stays in post until a successor takes over

Crauwels, who joined Sandvik in 2000, will remain in her position until a replacement is in place. She will then continue for a period in an advisory role to ensure a smooth transition. Sandvik has already started the recruitment process.

Departure follows a career spanning Sandvik Coromant and Group Executive Management

Before leading the Machining business area, Crauwels held several senior leadership positions at Sandvik, including President of Sandvik Coromant. She has also been a member of the Group Executive Management.

Calgary – October 12, 2026 -- XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU) said board chairman Anthony Giovinazzo is stepping down from the board of directors, citing personal reasons and a wish to pursue other interests.

Giovinazzo leaves after several years as chairman and committee member

Giovinazzo led the board as chairman for the past several years and also served on key committees. Co-CEO Dr. Allen Davidoff credited him with leadership and ethics of the highest standards in both roles. Davidoff said management and the board extend their appreciation for his efforts.

The company did not name a successor chairman or give a departure date. The release also did not say whether Giovinazzo's committee seats will be refilled.

XORTX advances five programs in gout and kidney disease

The late-stage clinical pharmaceutical company is developing three clinically advanced products: